08:51 AM EDT, 07/14/2025 (MT Newswires) -- Salarius Pharmaceuticals ( SLRX ) said Monday that it has received an extension until late July to regain compliance with the minimum stockholder equity criteria for listing on the Nasdaq stock market.

The minimum stockholder equity criteria require companies to maintain a minimum of $2.5 million in stockholders' equity for continued listing on the Nasdaq stock market.

Salarius reiterated that it must also regain compliance with Nasdaq's minimum bid price requirement by early August 2025.